[F. Theeuwes, Elementary osmotic pump, J. Pharm. Sci.64 (1975) 1987--1991.10.1002/jps.2600641218]Search in Google Scholar
[G. Santus and W. R. Baker, Osmotic drug delivery: A review of patent literature, J. Control. Rel.35 (1995) 1--21; DOI: 10.1016/0168-3659(95)00013-X.10.1016/0168-3659(95)00013-X]Search in Google Scholar
[R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Control. Rel.79 (2002) 7--27; DOI: 10.1016/S0168--3659 (01)00550-8.]Search in Google Scholar
[A. G. Thombre, J. R. Cardinal, A. R. DeNoto and D. C. Gibbs, Asymmetric membrane capsule for osmotic drug delivery II. In vitro and in vivo drug release performance, J. Control. Rel.57 (1999) 65--73; DOI: 10.1016/S0168-3659(98)00101-1.10.1016/S0168-3659(98)00101-1]Search in Google Scholar
[A. G. Thombre, J. R. Cardinal, A. R. DeNoto, S. M. Herbig and K. L. Smith, Asymmetric membrane capsule for osmotic drug delivery I. Development of manufacturing process, J. Control. Rel.57 (1999) 55--64; DOI: 10.1016/S0168-3659(98)00100-X.10.1016/S0168-3659(98)00100-X]Search in Google Scholar
[S. M. Herbig, J. R. Cardinal, R. W. Korsmeyer and K. L. Smith, Asymmetric membrane tablet coatings for osmotic drug delivery, J. Control. Rel.35 (1995) 127--136; DOI: 10.1016/0168-3659(95)00028-7.10.1016/0168-3659(95)00028-7]Search in Google Scholar
[Y.-K. Lin and H. Ho, Investigation on the drug releasing mechanism from an asymmetric membrane coated capsule with an in situ formed delivery orifice, J. Control. Rel.89 (2003) 57--69; DOI: 10.1016/S0168-3659(03)00091-9.10.1016/S0168-3659(03)00091-9]Search in Google Scholar
[G. M. Zentner, G. S. Rork and K. J. Himmelsteine, Osmotic flow through controlled porosity films: An approach to deliver water-soluble compounds, J. Control. Rel.2 (1985) 217--229.]Search in Google Scholar
[S. N. Makhija and P. R. Vavia, Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as semipermeable membrane, J. Control. Rel.89 (2003) 5--18; DOI: 10.1016/S0168-3659(02)00482-0.10.1016/S0168-3659(02)00482-0]Search in Google Scholar
[F. Theeuwes, D. R. Swanson, G. Guittard, A. Ayer and S. Khanna, Osmotic delivery systems for the beta-adrenoceptor anatagonists metoprolol and oxprenolol: design and evaluation for once-daily administration, Br. Clin. Pharmacol.19 (1985) 69S--76S.]Search in Google Scholar
[C. S. Chauhan and P. K. Choudhury, Controlled porosity osmotic pump for the delivery of flurbiprofen, Curr. Drug Deliv.3 (2006) 193--198.10.2174/15672010677635920316611005]Search in Google Scholar
[Martindale, The Extra Pharmacopoeia, 31st ed., Pharmaceutical Press, London, 1996, p. 999--1000.]Search in Google Scholar
[United States Pharmacopoeia 24, National Formulary 19, USP Convention, Rockville 2001, pp. 2051.]Search in Google Scholar
[N. T. Ende, S. M. Herbig, R. W. Korsmeyer and M. B. Chidlaw, Osmotic Drug Delivery from Asymmetric Membrane Film-Coated Dosage Form, in Hand Book of Pharmaceutical Controlled Release Technology (Ed. D. L. Wise), 1st ed., Marcel Dekker, New Jersey 2000, pp. 751--785.]Search in Google Scholar